Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Judith Bonsing"'
Autor:
Leslie van der Fits, Rineke de Jong, Karin Dijkman, Marjolein Heemskerk-van der Meer, Lisanne Tettero, Judith Bonsing, Sophie van Oort, Jan Serroyen, Marianke van Schie, Norbert Stockhofe-Zurwieden, Benoit Callendret, Roland Zahn
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-13 (2024)
Abstract Vaccination with Ad26.RSV.preF, an Adenoviral serotype 26 vector encoding RSV F protein stabilized in its prefusion conformation, has previously shown to be immunogenic and protective in RSV seropositive adults and immunogenic in seropositiv
Externí odkaz:
https://doaj.org/article/8b15c10cd47a4cbcb11b6592cfaf8b91
Autor:
Rineke de Jong, Norbert Stockhofe-Zurwieden, Judith Bonsing, Kai-Fen Wang, Sarah Vandepaer, Badiaa Bouzya, Jean-François Toussaint, Ilse Dieussaert, Haifeng Song, Ann-Muriel Steff
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
A pediatric RSV vaccine is an unmet medical need, even after >50 years of effort. Here, the authors show that a chimpanzee adenovirus based RSV vaccine candidate protects calves from disease upon RSV infection, regardless of the time after vaccinatio
Externí odkaz:
https://doaj.org/article/a59e99feeb0c41a997df7bed33028bd5
Autor:
Ilse Dieussaert, Badiaa Bouzya, Sarah Vandepaer, Judith Bonsing, Ann-Muriel Steff, Kai-fen Wang, Jean-François Toussaint, Norbert Stockhofe-Zurwieden, Haifeng Song, Rineke de Jong
Publikováno v:
Nature Communications 13 (2022) 1
Nature Communications, 13(1)
Nature Communications, 13(1)
Respiratory syncytial virus (RSV) infection causes a substantial lower-respiratory-tract disease burden in infants, constituting a global priority for vaccine development. We evaluated immunogenicity, safety and efficacy of a chimpanzee adenovirus (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9289537d597369c743c8209d3295311c
https://doi.org/10.1038/s41467-022-33649-3
https://doi.org/10.1038/s41467-022-33649-3